Equity Capital Markets
Monopar Therapeutics
12/24
|
$40.0 Million
Âé¶¹´«Ã½ served as bookrunner for Monopar Therapeutics Inc. on its RD and PIPE offering
Sub-Type
Registered Direct
Sector
Sub-Sector
Biopharma